Search

everythinglearnresearchcommunity

for

Search:↓

5-alpha reductase inhibitors slightly reduce urinary symptoms and may lower surgery and acute retention risks in men.

The study explains how minoxidil sulfate causes vasodilation in rabbits by opening potassium channels and inhibiting calcium channels.

PPARα agonists may help treat alopecia areata by reducing inflammation.

A specific gene mutation is linked to a hereditary form of dystonia that responds well to certain medications.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Kv1.3 blockers may help treat alopecia areata and promote hair regrowth.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

A new topical treatment for hair loss shows strong hair growth effects with low toxicity.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Female rats showed more panic-related behavior than males, influenced by hormonal cycles and certain drugs.

taVNS reduces vitiligo symptoms in mice.

Blocking allopregnanolone production in mice makes them more anxious after stress, but this can be reversed with a drug that mimics allopregnanolone.

Predstanormix Duo is a safe and effective new drug for treating urinary symptoms from BPH.

Neurosteroids affect prolactin levels in sheep differently depending on stress and pregnancy conditions.

Inhibiting certain enzymes made female rats more sensitive to low-level pain.

Targeting Vδ1+T-cells may help treat alopecia areata.

Liposomal anthracyclines are effective and safer for treating multiple myeloma, especially in elderly patients.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

5 alpha-reductase inhibitors can slightly improve symptoms of enlarged prostate but have a high risk of sexual side effects.

Vibration assisted analgesia reduces pain during corticosteroid therapy for alopecia.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Carbamates may help treat androgen-dependent conditions by changing how certain lipid enzymes are produced.

Beta-blockers and anti-anginal medications have various side effects and interactions that require careful monitoring and individualized treatment.

Tolterodine Tartrate effectively treats overactive bladder symptoms.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

RXR agonists may promote hair growth in humans.

Proxalutamide helps COVID-19 patients get rid of the virus faster and recover quicker.

Finasteride reduces prostate cancer risk but may increase high-grade tumors; new drugs and better diagnosis are in development, but funding and industry commitment are challenges.